Search research articles
Contact Us
Filters
Showing results (31-40 of 122) with videos related to
Page
of 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study
D L Fraker, H R Alexander, M Andrich, et al.
Cancer Research
|
August 15, 1988
Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat
M C Stovroff, D L Fraker, J A Swedenborg, et al.
Journal of the American College of Surgeons
|
November 21, 2000
Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies
S K Libutti, D L Barlett, D L Fraker, et al.
The Journal of Surgical Research
|
May 1, 1989
Altered macrophage activity and tumor necrosis factor: tumor necrosis and host cachexia
M C Stovroff, D L Fraker, W D Travis, et al.
AJR. American Journal of Roentgenology
|
September 2, 1998
Extraadrenal myelolipoma: MR imaging findings
B F Kammen, D E Elder, D L Fraker, et al.
The Journal of Experimental Medicine
|
July 1, 1988
Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity
D L Fraker, M C Stovroff, M J Merino, et al.
European Journal of Nuclear Medicine
|
November 1, 1995
Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbs
W C Barker, M P Andrich, H R Alexander, et al.
Cytokine
|
November 1, 1994
D-factor/leukaemia inhibitory factor: evidence for its role as a mediator in acute and chronic inflammatory disease
H R Alexander, K G Billingsley, M I Block, et al.
Surgical Oncology
|
August 1, 1992
Effective regional therapy of experimental cancer with paralesional administration of tumour necrosis factor-alpha + interferon-gamma
A K Thom, D L Fraker, J K Taubenberger, et al.
Cancer
|
December 10, 1997
Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics
D L Bartlett, G Ma, H R Alexander, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 122) with videos related to
Sort By:
Page
of 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study
D L Fraker, H R Alexander, M Andrich, et al.
Cancer Research
|
August 15, 1988
Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat
M C Stovroff, D L Fraker, J A Swedenborg, et al.
Journal of the American College of Surgeons
|
November 21, 2000
Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies
S K Libutti, D L Barlett, D L Fraker, et al.
The Journal of Surgical Research
|
May 1, 1989
Altered macrophage activity and tumor necrosis factor: tumor necrosis and host cachexia
M C Stovroff, D L Fraker, W D Travis, et al.
AJR. American Journal of Roentgenology
|
September 2, 1998
Extraadrenal myelolipoma: MR imaging findings
B F Kammen, D E Elder, D L Fraker, et al.
The Journal of Experimental Medicine
|
July 1, 1988
Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity
D L Fraker, M C Stovroff, M J Merino, et al.
European Journal of Nuclear Medicine
|
November 1, 1995
Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbs
W C Barker, M P Andrich, H R Alexander, et al.
Cytokine
|
November 1, 1994
D-factor/leukaemia inhibitory factor: evidence for its role as a mediator in acute and chronic inflammatory disease
H R Alexander, K G Billingsley, M I Block, et al.
Surgical Oncology
|
August 1, 1992
Effective regional therapy of experimental cancer with paralesional administration of tumour necrosis factor-alpha + interferon-gamma
A K Thom, D L Fraker, J K Taubenberger, et al.
Cancer
|
December 10, 1997
Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics
D L Bartlett, G Ma, H R Alexander, et al.
Page
of 13